0001104659-19-027585.txt : 20190507
0001104659-19-027585.hdr.sgml : 20190507
20190507194058
ACCESSION NUMBER: 0001104659-19-027585
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190101
FILED AS OF DATE: 20190507
DATE AS OF CHANGE: 20190507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nally Michael
CENTRAL INDEX KEY: 0001763945
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 19804776
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
3/A
1
a3a.xml
3/A
X0206
3/A
2019-01-01
2019-01-10
0
0000310158
Merck & Co., Inc.
MRK
0001763945
Nally Michael
MERCK & CO., INC.
2000 GALLOPING HILL ROAD
KENILWORTH
NJ
07033
0
1
0
0
EVP, Chief Marketing Officer
Common Stock
100.0000
D
Common Stock - 401(k) Plan
1365.9535
I
By 401(k)
Restricted Stock Unit
2019-05-04
2021-05-04
Common Stock
3896.0000
D
Restricted Stock Unit
2019-05-10
2019-05-10
Common Stock
1811.0000
D
Restricted Stock Unit
2019-10-30
2021-10-30
Common Stock
6862.0000
D
Restricted Stock Unit
2020-05-05
2020-05-05
Common Stock
2345.0000
D
Stock Option (right to buy)
54.6800
2017-05-10
2026-05-09
Common Stock
7471.0000
D
Stock Option (right to buy)
57.7500
2019-05-04
2028-05-03
Common Stock
27447.0000
D
Stock Option (right to buy)
63.9700
2018-05-05
2027-05-04
Common Stock
14266.0000
D
The original Form 3, filed on January 10, 2019, is being amended by this Form 3 amendment solely to correct the total number of shares beneficially owned by the reporting person to include 100 shares of Merck common stock held in a joint account with the reporting person and the reporting person's parent.
Includes shares acquired and dividends earned through January 1, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.
The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/19 and 5/5/2020.
Faye C. Brown as Attorney-in-Fact for Michael Nally
2019-05-07